DiaMedica Therapeutics Inc. (DMAC)
NASDAQ·Healthcare·Biotechnology
$5.77
+1.05%
Mkt Cap $303.36M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$8.33
Range $7.00 – $10.00
Implied Upside
+44.4%
Consensus $8.33 vs current $5.77
NASDAQ·Healthcare·Biotechnology
$5.77
+1.05%
Mkt Cap $303.36M
No recent rating data.
Price Target (3 analysts)
$8.33
Range $7.00 – $10.00
+44.4%
Consensus $8.33 vs current $5.77